Daniel A. Peisert, SVP and CFO at Assertio Therapeutics, Inc (ASRT), bought 10,000 shares at $0.73 ($7K) on 2019-11-11, disclosed to the SEC on 2019-11-12.
Open-market purchase of $7k ASRT by SVP and CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| ASRT | SELL | 2022-04-07 | $121K | — | Filing → |
| ASRT | BUY | 2021-05-24 | $24K | — | Filing → |
| ASRT | BUY | 2019-08-20 | $21K | — | Filing → |